DIABETIC PERIPHERAL NEUROPATHIC PAIN
Clinical trials for DIABETIC PERIPHERAL NEUROPATHIC PAIN explained in plain language.
Never miss a new study
Get alerted when new DIABETIC PERIPHERAL NEUROPATHIC PAIN trials appear
Sign up with your email to follow new studies for DIABETIC PERIPHERAL NEUROPATHIC PAIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for diabetic nerve pain? early trial underway
Symptom relief Recruiting nowThis study tests a new medicine called HRS-2129 for people with diabetic nerve pain in their hands and feet. About 168 Chinese adults will receive either the new drug, a placebo (dummy pill), or an approved painkiller (pregabalin) to see if it safely reduces pain. The main goal i…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Symptom relief
Last updated May 17, 2026 01:00 UTC
-
New pill could ease diabetic nerve pain without opioids
Symptom relief Recruiting nowThis study tests a new medicine called suzetrigine for people with diabetic peripheral neuropathy, a type of nerve pain in the legs and feet caused by diabetes. About 734 adults with diabetes and long-term nerve pain will receive either the drug or a placebo for 12 weeks. The goa…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated May 17, 2026 00:53 UTC
-
New hope for diabetic nerve pain: experimental drug enters phase 2 trial
Symptom relief Recruiting nowThis study tests a new medicine called LY4065967 to see if it safely reduces nerve pain in people with diabetes. About 150 adults with diabetic nerve pain in their legs for at least 6 months will receive either the study drug or a placebo. The main goal is to measure changes in a…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated May 17, 2026 00:47 UTC
-
New painkiller for diabetic nerve pain enters final testing phase
Symptom relief Recruiting nowThis study tests a new medicine called suzetrigine for people with painful nerve damage from diabetes. About 1,100 adults will receive either the study drug, a placebo, or an active comparator to see if it safely reduces pain over 12 weeks. The goal is to find a new option for ma…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC
-
New pill aims to ease burning nerve pain in diabetes patients
Symptom relief Recruiting nowThis study tests an experimental oral medication called VX-993 for people with painful nerve damage from diabetes (diabetic peripheral neuropathy). About 300 adults will receive either VX-993, an active comparator, or placebo to see if it safely reduces daily pain over 12 weeks. …
Matched conditions: DIABETIC PERIPHERAL NEUROPATHIC PAIN
Phase: PHASE2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC